FDA Approved: FULVESTRANT — Original Application (Sagent Pharmaceuticals)

View source ↗

Summary

FDA approved an original application for a generic fulvestrant product from Sagent Pharmaceuticals for breast cancer treatment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Fulvestrant (fulvestrant)

Snippet

ORIG AP for FULVESTRANT (FULVESTRANT)